TABLE 3.
Currently Approved Cancer Agents With Target Molecules on Host Immune Cells (Immune Modulators)
Category | Agent | Class | Molecular Target | FDA-Approved Indication |
---|---|---|---|---|
Immune modulators | Ipilimumab (Yervoy, Bristol-Myers Squibb) | mAb | CTLA | Melanoma |
Note—FDA = Food and Drug Administration, mAb = monoclonal antibody, CTLA = cytotoxic T-lymphocyte antigen.